{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:54:12Z","timestamp":1776315252506,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study investigated changes in body composition before and after neoadjuvant therapy in patients with gastric cancer and explored the relationships between these changes, relative dose intensity (RDI), and hematological toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Body composition parameters (muscle mass, skeletal muscle mass, body fat mass, visceral fat area, and water content) were measured via an InBody 720 analyzer before and after treatment. The primary outcome was a reduced RDI (&amp;lt;85%), and the secondary outcome was Grade 2 or 3 hematological toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with a reduced RDI (&amp;lt;85%) presented significant decreases in muscle mass, skeletal muscle mass, and total body water content after therapy and had longer treatment duration. Greater muscle mass, skeletal muscle mass, and total body water content were associated with lower risks of reduced RDI [OR: 0.808 (0.697\u20130.938)], [OR: 0.699 (0.545\u20130.897)], and [OR: 0.759 (0.626\u20130.920)], respectively. Grade 2 thrombocytopenia was associated with reduced muscle mass and total body water, as well as increased body fat mass and visceral fat area. In further regression analyses, greater skeletal muscle mass was associated with a lower risk of grade 2 thrombocytopenia [OR: 0.657 (0.434\u20130.996)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher muscle mass and total body water were associated with a lower risk of reduced RDI, whereas body fat mass showed no significant association. Regarding hematologic toxicity, grade 2 thrombocytopenia was associated with adverse changes in body composition, and greater skeletal muscle mass was associated with a lower risk in the adjusted analysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1753568","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:20:42Z","timestamp":1776313242000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Body composition\u2013based nutritional status during neoadjuvant chemotherapy and its association with relative dose intensity and hematologic toxicity in patients with gastric cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Guoqing","family":"Shi","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penghui","family":"Liu","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Gao","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University","place":["Lanzhou, Gansu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Du","sequence":"additional","affiliation":[{"name":"Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwu","family":"Guo","sequence":"additional","affiliation":[{"name":"Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Mao","sequence":"additional","affiliation":[{"name":"Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s11864-022-01004-9","article-title":"Neoadjuvant and adjuvant therapy approaches to gastric cancer","volume":"23","author":"Fong","year":"2022","journal-title":"Curr Treat Options in Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cac2.12516","article-title":"The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023","volume":"44","author":"Wang","year":"2024","journal-title":"Cancer Commun"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e000770","DOI":"10.1136\/esmoopen-2020-000770","article-title":"Sex differences in cancer chemotherapy effects, and why we need to reconsider BSA-based dosing of chemotherapy","volume":"5","author":"Wagner","year":"2020","journal-title":"ESMO Open"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s11764-023-01380-7","article-title":"Body composition and chemotherapy toxicity among women treated for breast cancer: a systematic review","volume":"18","author":"Wopat","year":"2024","journal-title":"J Cancer Surviv"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"103666","DOI":"10.1016\/j.esmoop.2024.103666","article-title":"Bioimpedance-derived body composition parameters predict mortality and dose-limiting toxicity: the multicenter ONCO-BIVA study","volume":"9","author":"Cereda","year":"2024","journal-title":"ESMO Open"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1017\/S0007114521002579","article-title":"Tracking changes in body composition: comparison of methods and influence of pre-assessment standardisation","volume":"127","author":"Tinsley","year":"2022","journal-title":"Br J Nutr"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.3390\/nu15224792","article-title":"Bioelectrical impedance analysis (BIA) for the assessment of body composition in oncology: a scoping review","volume":"15","author":"Branco","year":"2023","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"13419","DOI":"10.1038\/s41598-022-17611-3","article-title":"CT-derived body composition analysis could possibly replace DXA and BIA to monitor NET-patients","volume":"12","author":"Kroll","year":"2022","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/jcm10051079","article-title":"Role of baseline computed-tomography-evaluated body composition in predicting outcome and toxicity from first-line therapy in advanced gastric cancer patients","volume":"10","author":"Catanese","year":"2021","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1158\/1055-9965.EPI-23-0227","article-title":"Body composition, relative dose intensity, and adverse events among patients with colon cancer","volume":"32","author":"Cheng","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10147-022-02260-3","article-title":"Relative dose intensity and 1-year psoas muscle index reduction rate as prognostic factors in gastric cancer patients with postoperative adjuvant chemotherapy","volume":"28","author":"Fujita","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s10147-019-01468-0","article-title":"Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II\/III gastric cancer","volume":"24","author":"Miyatani","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1249\/MSS.0000000000002828","article-title":"Physical fitness and chemotherapy tolerance in patients with early-stage breast cancer","volume":"54","author":"Groen","year":"2022","journal-title":"Med Sci Sports Exerc"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.clcc.2023.02.007","article-title":"Incidence of disease recurrence in patients with colon and upper rectum adenocarcinoma stage II and III receiving adjuvant capecitabine monotherapy: do number of chemotherapy cycles and relative dose intensity of the drug play a role?","volume":"22","author":"Sgouros","year":"2023","journal-title":"Clin Colorectal Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1272","DOI":"10.1093\/oncolo\/oyae123","article-title":"Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancer","volume":"29","author":"Chan","year":"2024","journal-title":"Oncologist"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/nu15010129","article-title":"Body composition of young women and the consumption of selected nutrients","volume":"15","author":"Karpi\u0144ska","year":"2022","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10549-011-1949-5","article-title":"Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice","volume":"133","author":"Weycker","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.adengl.2019.05.021","article-title":"Using the common terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/nejm199504063321401","article-title":"Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up","volume":"332","author":"Bonadonna","year":"1995","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1200\/jco.22.01440","article-title":"Low-intensity adjuvant chemotherapy for breast cancer in older women: results from the prospective multicenter HOPE trial","volume":"41","author":"Sedrak","year":"2023","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00595-023-02737-2","article-title":"Preoperative low skeletal muscle volume can result in insufficient administration of S-1 adjuvant chemotherapy in older patients with stage II\/III gastric cancer","volume":"54","author":"Kono","year":"2024","journal-title":"Surg Today"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clnesp.2021.10.009","article-title":"Extracellular water to total body water ratio may mediate the association between phase angle and mortality in patients with cancer cachexia: a single-center, retrospective study","volume":"46","author":"Katsura","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.21873\/anticanres.14928","article-title":"Extracellular water-to-total body water ratio as an objective biomarker for frailty in lung cancer patients","volume":"41","author":"Hirashima","year":"2021","journal-title":"Anticancer Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.21873\/anticanres.14384","article-title":"The association between extracellular water-to-total body water ratio and therapeutic durability for advanced lung cancer","volume":"40","author":"Noda","year":"2020","journal-title":"Anticancer Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1111\/jgh.15377","article-title":"Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma","volume":"36","author":"Yamaoka","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/009885881203800403","article-title":"Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs","volume":"38","author":"Hottinger","year":"2012","journal-title":"Am J Law Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e37563","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-019-05352-3","article-title":"Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review","volume":"177","author":"Aleixo","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00595-019-01915-5","article-title":"What is the most useful body composition parameter for predicting toxicities of preoperative chemotherapy for gastric cancer?","volume":"50","author":"Hashimoto","year":"2020","journal-title":"Surg Today"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-014-2843-8","article-title":"Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients","volume":"144","author":"Wong","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00520-023-07890-5","article-title":"Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapy","volume":"31","author":"Jang","year":"2023","journal-title":"Support Care Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00280-017-3326-5","article-title":"Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity","volume":"80","author":"Bretagne","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jpen.1440","article-title":"GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community","volume":"43","author":"Jensen","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/01.mco.0000165011.69943.39","article-title":"Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations","volume":"8","author":"Barbosa-Silva","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1753568\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:20:42Z","timestamp":1776313242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1753568\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":36,"alternative-id":["10.3389\/fnut.2026.1753568"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1753568","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1753568"}}